Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Sanara MedTech Inc. SMTI
$41.30
+$1.35 (3.28%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
317649394.00000000
-
week52high
50.18
-
week52low
17.41
-
Revenue
45842845
-
P/E TTM
-15
-
Beta
1.82318300
-
EPS
-0.95000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 20:00
Описание компании
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Cantor Fitzgerald | Overweight | 30 июн 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fleming Zachary B. | D | 34474 | 325 | 02 дек 2022 г. |
| Fleming Zachary B. | D | 34799 | 1471 | 02 дек 2022 г. |
| McNeil Michael D. | D | 19251 | 253 | 02 дек 2022 г. |
| McNeil Michael D. | D | 19504 | 865 | 02 дек 2022 г. |
| Bowman Shawn M. | D | 11469 | 4414 | 02 дек 2022 г. |
| Bowman Shawn M. | D | 15883 | 260 | 02 дек 2022 г. |
| Bowman Shawn M. | D | 16143 | 82 | 02 дек 2022 г. |
| Bowman Shawn M. | D | 16225 | 1101 | 02 дек 2022 г. |
| Bowman Shawn M. | D | 17326 | 1224 | 02 дек 2022 г. |
| Fleming Zachary B. | D | 36270 | 417 | 08 ноя 2022 г. |
Новостная лента
What Makes Sanara MedTech Inc. (SMTI) a Good Fit for 'Trend Investing'
Zacks Investment Research
03 февр 2023 г. в 10:32
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sanara MedTech Inc. (SMTI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Sanara MedTech: A High Growth Micro Cap Disrupting The Wound And Skin Care Space
Seeking Alpha
09 дек 2022 г. в 12:22
A micro cap health tech company following a path to large cap potential. A management team with vision, ownership, operational expertise, domain knowledge and that trust each other.
Sanara MedTech: Triple-Digit Revenue Upside In Q3, Expanding Footprint, Reaffirm Buy
Seeking Alpha
08 дек 2022 г. в 04:24
Tremendous growth during the quarter with 124% revenue upside from this time last year. Continues to expand its footprint and sales channels, pushing towards its market goals.
Sanara Medtech, Inc. (SMTI) Q3 2022 Earnings Call Transcript
Seeking Alpha
15 ноя 2022 г. в 13:59
Sanara Medtech, Inc. (NASDAQ:SMTI ) Q3 2022 Earnings Conference Call November 15, 2022 9:00 AM ET Company Participants Callon Nichols - Director, IR Ronald Nixon - Executive Chairman Zachary Fleming - CEO Michael McNeil - CFO & Corporate Secretary Conference Call Participants Christopher Plahm - Tall Pines Capital Ian Cassel - MicroCapClub Operator Good day, ladies and gentlemen, and welcome to the Sanara MedTech Inc. Q3 2022 Earnings and Business Update. [Operator Instructions].
Sanara MedTech Inc. Announces Third Quarter 2022 Earnings Release and Conference Call Dates
GlobeNewsWire
01 ноя 2022 г. в 09:15
FORT WORTH, TX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today details for the release of its results for the quarter ended September 30, 2022.